Stay updated on Dolutegravir Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Rilpivirine Clinical Trial page.

Latest updates to the Dolutegravir Rilpivirine Clinical Trial page
- Check2 days agoChange Detected- Revision updated from v3.6.4 to v3.6.5. This appears to be a small patch; no substantive content changes are introduced.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, representing a version bump. It is a metadata-only change that does not affect the study details, eligibility criteria, or results shown on the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a modification to the page’s versioning/metadata. This change does not alter the study information presented on the page.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2. This reflects a new page build rather than changes to the study details.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the Lancet citation for the SWORD-1/SWORD-2 studies from the Publications section.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows that the study is no longer recruiting participants, signaling completion; it also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the heading to an Intervention/Treatment section, with a revision label of Revision: v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Dolutegravir Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Rilpivirine Clinical Trial page.